A Vaccine Hub to Solve Pressing Healthcare Priorities

Vaccine Influencers Lead in Maryland 

Maryland is an innovative leader in vaccine research and development with fully 20 percent of the world’s top influencers in vaccine development in the state. In Montgomery County, find some of the top vaccine companies advancing life-saving vaccines to fight infectious diseases. With one of the largest and most robust life sciences clusters in the nation, Montgomery County is also a prime location with the presence of the NIH, the FDA, and NIST.

Maryland is #1 in NIH Research & Development Contract Awards

Maryland is #1 in Concentration of Employed Doctoral Scientists in MD

91.5% Increase in STEM degrees in the Univ of MD System since 2009

Cost of Wet lab space in MD is $24.35 per SF, less than ½ the cost of San Francisco or Boston

Major vaccine companies in MoCo include GSK, Novavax, Altimmune and Emergent BioSolutions

$556 Million in VC investment to MoCo companies Jan to July 2018, with 72% to Biotech companies


0
M

SF of wet lab space

0
%

of Top vaccine development influencers are in MD

0
+

BioHealth companies in MoCo

0
K

Biotech Workers and 6,000 STEM PHDs in Talent-Rich MoCo


Finding Public Health Solutions 

Vaccines are among the most successful and cost-effective public health tools available for preventing disease and death, and they remain the best defense against the flu and several serious diseases like measles and diphtheria. Medical advancements and research have led to the development of vaccinations that protect against dozens of diseases. The numbers tell the story—when immunization rates are high, whole communities around the world are better protected.

Meet Some of the County’s Thriving Vaccine Companies 

GlaxoSmithKline (GSK) opened a global vaccines R&D Center in Rockville in 2016. It is a state-of-the-art facility that employs more than 450 scientists and support staff. GSK vaccines run the gamut including childhood vaccines against diseases such as measles, meningitis and pneumonia, helping to protect the developing immune systems of infants and preventing millions of deaths each year.

We are delighted to be opening our new facility in Rockville, GSK’s first fully dedicated vaccines R&D center located in the US. Our investment here signifies our commitment to discovering and developing new vaccines across a range of pressing public health priorities, including those important here in the US. It places GSK at the heart of a dynamic and cutting edge bioscience hub in Washington, D.C.

Luc Debruyne, President, GSK Vaccines

Altimmune is a clinical stage immunotherapeutic biotech company based in in Gaithersburg. The company has created NasoVAX, a new way to fight the flu with a product that mobilizes the immune system in ways that conventional vaccines cannot. It is also developing a NasoShield Anthrax vaccine.  

Emergent BioSolutions is based in Gaithersburg, and found growth and new opportunity when it moved to Maryland from another state. Emergent manufactures BioThrax, the only FDA-licensed vaccine to protect against anthrax disease.

Novavax is a clinical stage biotech company in Gaithersburg that is committed to deliver products to prevent a range of infection diseases. They use innovative proprietary technology and have a product pipeline targeting a variety of infection diseases including seasonal influenza and Ebola virus. 

Sanaria is a Rockville-based biotechnology company that is developing vaccines to protect against malaria. The company was the recipient of Montgomery County’s Small Business Awards as its Bioscience Company of the Year in 2015. Sanaria’s vaccines have proven highly protective in humans. One million people die from malaria each year, and children are frequently among the most affected groups.  

Synam has a mission to eradicate pneumococcal diseases—from pneumonia, middle ear infections to meningitis—with the world’s first universal vaccine. The company is located in the  Rockville Innovation Center which serves as a business incubator for emerging companies and is fully fitted with wet lab space. 

18 Federal Agency Headquarters in Montgomery County

With dozens of Federal research institutes and several top-ranking research universities focusing on vaccine research in the area, it’s no wonder that innovative vaccine research and development has become an important sector in the growing BioHealth presence. Significant vaccine influencers are strong contributors to the field of vaccines and immunization.throughout our region. Proximity to so many potential customers, employees and collaborators is another major advantage for emerging and established companies. 

Federal support includes the following:

The National Institutes of Health (NIH), the nation’s medical research agency, making important discoveries that improve health and save lives. The agency encompasses 27 Institutes and Centers. 

National Cancer Institute (NCI) is a part of NIH. Located in Rockville, NCI leads the nation’s research efforts to improve cancer prevention, detection, diagnosis, and survivorship. It supports thousands of clinical trials and collaborates with private sector life sciences companies and federal agencies. 

Montgomery County’s Vaccine Research Center (VRC), within NIH is the Vaccine Research Center, established to further research in vaccine development. The VRC is dedicated to improving global human health—and Maryland is a leader in creation and production of effective vaccines for human diseases. VRC is part of the National Institute of Allergy and Infectious Diseases.  

The Food and Drug Administration (FDA) protects the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products.

Support Resources in Abundance

BioHealth Innovation (BHI) helps companies commercialize their technologies and advance to market by introducing entrepreneurs to sources of capital and private investment. BHI operates County’s innovation centers/incubators in Rockville and Germantown, co-manages shared lab space in Alexandria LaunchLabs, and assists BioHealth companies seeking to enter the US market with its International Soft-Landing program. BHI continues to be instrumental in not only providing valuable resources but branding the region as a global BioHealth leader. 

TEDCO helps companies by ‘leading innovation to market.” TEDCO provides resources and connections that early stage technology and life sciences companies need to thrive across Maryland. TEDCO has an assessment tool to help define your investment readiness.

BioHealth Incentives and Funding

As BioHealth continues to be such an important part of Montgomery County’s business growth, a number of incentives are in place to help companies start and grow.  The County and state both have incentives to explore. 

Maryland Biotechnology Investment Incentive Tax Credit (BIITC) provides an income tax credit equal to 50% of an eligible investment in a Qualified Maryland Biotechnology Company (QMBC) up to $250,000 for each QMBC per fiscal year.

Venture Capital Funding in Montgomery County helps investors recognize the innovation happening in Montgomery County. From January to July 2018, $556 Million flowed in from venture capital investment dollars to MoCo companies. A strong 72% of the 2018 VC investment has been in the biotech area.


Gaithersburg, MD

We are proud that MedImmune, a global company with a rich history and promising future, is based right here in Gaithersburg, MD. With one of the largest and most robust biologics pipelines in the life sciences industry, MedImmune has made immense strides with worldwide impact. The company is focused on three core therapeutic areas: Oncology; Respiratory, Inflammation and Autoimmune; and Cardiovascular and Metabolic Disease. 

Connect

Spiros_Balntas_1134_sm.jpg

SPIROS BALNTAS
Director of Business Recruitment

240.641.6705
spiros@thinkmoco.com